These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30365949)

  • 1. Antiviral efficacy of the helicase-primase inhibitor amenamevir in murine models of severe herpesvirus infection.
    Katsumata K; Chono K; Suzuki H
    Biochem Pharmacol; 2018 Dec; 158():201-206. PubMed ID: 30365949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of virus strains resistant to the herpes virus helicase-primase inhibitor ASP2151 (Amenamevir).
    Chono K; Katsumata K; Kontani T; Shiraki K; Suzuki H
    Biochem Pharmacol; 2012 Aug; 84(4):459-67. PubMed ID: 22687623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
    Yajima M; Yamada H; Takemoto M; Daikoku T; Yoshida Y; Long T; Okuda T; Shiraki K
    Antiviral Res; 2017 Mar; 139():95-101. PubMed ID: 28027917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of ASP2151, a helicase-primase inhibitor, in a murine model of herpes simplex virus infection.
    Katsumata K; Chono K; Kato K; Ohtsu Y; Takakura S; Kontani T; Suzuki H
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1339-46. PubMed ID: 23274658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicase-primase inhibitor amenamevir for herpesvirus infection: Towards practical application for treating herpes zoster.
    Shiraki K
    Drugs Today (Barc); 2017 Nov; 53(11):573-584. PubMed ID: 29451274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster.
    Shiraki K; Yasumoto S; Toyama N; Fukuda H
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ASP2151, a herpesvirus helicase-primase inhibitor, in a guinea pig model of genital herpes.
    Katsumata K; Chono K; Sudo K; Shimizu Y; Kontani T; Suzuki H
    Molecules; 2011 Aug; 16(9):7210-23. PubMed ID: 21869749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Chono K; Katsumata K; Suzuki H; Shiraki K
    Antiviral Res; 2013 Feb; 97(2):154-60. PubMed ID: 23261844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of herpes virus helicase-primase inhibitor, ASP2151, for treating herpes simplex keratitis in mouse model.
    Sasaki S; Miyazaki D; Haruki T; Yamamoto Y; Kandori M; Yakura K; Suzuki H; Inoue Y
    Br J Ophthalmol; 2013 Apr; 97(4):498-503. PubMed ID: 23361434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model.
    Uhlig N; Donner AK; Gege C; Lange F; Kleymann G; Grunwald T
    Antiviral Res; 2021 Nov; 195():105190. PubMed ID: 34666109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of herpes simplex virus isolated from genital herpes lesions to ASP2151, a novel helicase-primase inhibitor.
    Katsumata K; Weinberg A; Chono K; Takakura S; Kontani T; Suzuki H
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3587-91. PubMed ID: 22526302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.
    Shiraki K; Tan L; Daikoku T; Takemoto M; Sato N; Yoshida Y
    Antiviral Res; 2020 Aug; 180():104829. PubMed ID: 32569704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of ASP2151, a helicase-primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo.
    Himaki T; Masui Y; Chono K; Daikoku T; Takemoto M; Haixia B; Okuda T; Suzuki H; Shiraki K
    Antiviral Res; 2012 Feb; 93(2):301-304. PubMed ID: 22155691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections.
    Biswas S; Sukla S; Field HJ
    Future Med Chem; 2014 Jan; 6(1):45-55. PubMed ID: 24358947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High conservation of herpes simplex virus UL5/UL52 helicase-primase complex in the era of new antiviral therapies.
    Collot M; Rouard C; Brunet C; Agut H; Boutolleau D; Burrel S
    Antiviral Res; 2016 Apr; 128():1-6. PubMed ID: 26826441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSV antivirals - current and future treatment options.
    Birkmann A; Zimmermann H
    Curr Opin Virol; 2016 Jun; 18():9-13. PubMed ID: 26897058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacement of sulfonamide by sulfoximine within a helicase-primase inhibitor with restricted flexibility.
    Gege C; Kleymann G
    Bioorg Med Chem Lett; 2024 Jul; 106():129761. PubMed ID: 38642810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UL52 primase interactions in the herpes simplex virus 1 helicase-primase are affected by antiviral compounds and mutations causing drug resistance.
    Muylaert I; Zhao Z; Elias P
    J Biol Chem; 2014 Nov; 289(47):32583-92. PubMed ID: 25278021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
    Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
    Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.